Short answer
Cartesian Therapeutics, Inc. (RNAC) filed an 8-K current report with the SEC on June 17, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 24,151,536 shares represented, covering approximately 82.42% of outstanding shares.
Cartesian Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 24,151,536 shares represented, covering approximately 82.42% of outstanding shares
- All three Class I nominees elected through the 2029 annual meeting
- Timothy A. Springer received 18,665,163 votes, while Michael Singer and Patrick Zenner had 8,083,506 and 7,660,206 withheld
- Executive compensation approved on an advisory basis, with 13,659,709 votes for and 6,033,199 abstentions
- Ernst & Young LLP appointment ratified for 2026 with 24,144,742 votes for
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cartesian Therapeutics, Inc. 8-K filings
Get the next RNAC 8-K as it lands
Follow RNAC for push alerts, or ask the research agent what this filing means.